Johannesburg, November, 2011 — Efforts to fill the gap in drug discovery and clinical research capability in SouthAfrica (SA) are being accelerated by an innovative partnership between multinational drug company Novartis and local universities. “There is a need for more post graduate students and more skills in clinical research and the basic drug discovery sciences in Africa,” explains Novartis Clinical Pharmacologist and Head of Scientific Capability Development, Colin Pillai. “It’s clear that independent efforts by academic institutions, the pharmaceutical industry and governments can’t develop research capability in Africa at a rapid enough pace to match the critical need – they... Continue Reading
Fred Maina, the Academic Director of the Model Centre for Deaf Education and Training (MoCeDET), has called for the involvement of deaf and other disabled..
9 November 2011 – “You’re not going to increase generic usage just by decreasing price,” said Alan Sheppard, Global Head of Generics Thought Leadership for IMS Health. He was speaking at the International Generics Pharmaceutical Alliance (IGPA) conference in Cape Town last week. While generic medicines are an essential part of making healthcare affordable in South Africa, the reluctance of doctors, pharmacists, and patients to use them has hindered their usage. Pharmacists and doctors not helping generic adoption Simply lowering the price will not lead to wider adoption of generics. One of the main reasons for this is that consumers... Continue Reading
Entries open for the 2011/2 Novo Nordisk Media Prize Novo Nordisk, a global leader in diabetes care, is now accepting entries for the 2011/2 Novo Nordisk Media Prize. “With the prevalence of diabetes increasing throughout the world, there is a greater need to provide the public with information about the disease,” says Shelley Harris, the PR Manager at Novo Nordisk South Africa. “The media plays a significant role in getting the message out about the various aspects of the diabetes and the management of the two different types of diabetes; we therefore established this prize to reward well-researched, clear and... Continue Reading
Johannesburg, November 8, 2011 — Efforts to fill the gap in drug discovery and clinical research capability in South Africa (SA) are being accelerated by an innovative partnership between multinational drug company Novartis and local universities. “There is a need for more post graduate students and more skills in clinical research and the basic drug discovery sciences in Africa,” explains Novartis Clinical Pharmacologist and Head of Scientific Capability Development, Colin Pillai. “It’s clear that independent efforts by academic institutions, the pharmaceutical industry and governments can’t develop research capability in Africa at a rapid enough pace to match the critical need... Continue Reading
